|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.22 USD | -0.75% |
|
+0.11% | -31.65% |
| May. 06 | Hudson Technologies Signs Licensing Agreement With Chemours | MT |
| May. 06 | Hudson Technologies Enters into Licensing Agreement with Chemours | CI |
Hudson Technologies, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 325.23 million compared to USD 192.75 million a year ago. Net income was USD 103.8 million compared to USD 32.26 million a year ago.
Basic earnings per share from continuing operations was USD 2.31 compared to USD 0.74 a year ago. Diluted earnings per share from continuing operations was USD 2.2 compared to USD 0.69 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.65% | 420M | |
| +36.24% | 75.21B | |
| +14.53% | 59.29B | |
| +9.72% | 46.83B | |
| +18.29% | 45.93B | |
| +12.47% | 17.93B | |
| +12.66% | 17.92B | |
| +5.25% | 12.73B | |
| -17.12% | 10.75B | |
| +2.64% | 6.23B |
HUDSON TECHNOLOGIES, INC. 